山东科学 ›› 2024, Vol. 37 ›› Issue (4): 1-8.doi: 10.3976/j.issn.1002-4026.20230126

• 中药与天然活性产物 •    下一篇

小建中合剂活性炭除杂工艺优化及其制剂稳定性影响研究

张微1,2(), 刘震远1,2, 杜昊忱1,2,*(), 郭田甜1,2, 杨梅1,3, 王善栋1,3, 韩培1,2, 宋祥云3, 张贵民2,3,*()   

  1. 1.鲁南厚普制药有限公司 中药制药共性技术山东省工程研究中心,山东 临沂 276006
    2.鲁南制药集团股份有限公司 经方与现代中药融合创新全国重点实验室,山东 临沂 276006
    3.鲁南制药集团股份有限公司,山东 临沂 276006
  • 收稿日期:2023-08-28 出版日期:2024-08-20 发布日期:2024-08-05
  • 通信作者: 杜昊忱,张贵民 E-mail:zhangxiaowei6578@163.com;duhaochen1002@163.com;lunanzhangguimin@163.com
  • 作者简介:张微(1985—),女,硕士,副主任药师,研究方向为中药新药研发与质量控制。E-mail:zhangxiaowei6578@163.com
  • 基金资助:
    山东省重点研发计划项目(2021CXGC010508);山东省新旧动能转换重大产业攻关项目(鲁动能办[2021]23号)

Optimization of activated charcoal impurity removal process for Xiaojianzhong mixture and its impacton the stability of the mixture’s preparations

ZHANG Wei1,2(), LIU Zhenyuan1,2, DU Haochen1,2,*(), GUO Tiantian1,2, YANG Mei1,3, WANG Shandong1,3, HAN Pei1,2, SONG Xiangyun3, ZHANG Guimin2,3,*()   

  1. 1. Shandong Engineering Research Center of Generic Manufacture Technology of Traditional Chinese Medicine,Lunan Hope Pharmaceutical Co., Ltd., Linyi 276006, China
    2. State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi 276006, China
    3. Lunan Pharmaceutical Group Co.,Ltd.,Linyi 276006,China
  • Received:2023-08-28 Online:2024-08-20 Published:2024-08-05
  • Contact: DU Haochen, ZHANG Guimin E-mail:zhangxiaowei6578@163.com;duhaochen1002@163.com;lunanzhangguimin@163.com

摘要:

为提高小建中合剂制剂澄清度与稳定性,选用活性炭除杂工艺纯化小建中合剂,采用正交试验评价法,以活性炭的用量、煮炭时间、除炭时的药液温度为考察因素,以芍药苷转移率、干物质转移率为考察指标,进行方差分析、直观分析结合加速稳定性试验结果,优选小建中合剂活性炭除杂工艺,并在该条件下生产3批小建中合剂制剂进行长期稳定性试验。结果表明小建中合剂制剂煮炭除杂最佳工艺参数为活性炭使用量0.4%、煮炭时间30 min及滤过时药液温度100 ℃,此工艺条件扩大生产的平均芍药苷转移率为75.24%、干物质转移率为89.08%。该试验所得最佳煮炭除杂工艺可保证小建中合剂澄清度及稳定性,同时最大程度保留芍药苷及干物质,从而保证药品疗效的稳定均一,为小建中合剂煮炭除杂纯化工艺参数的明确及优化提供了科学、合理的依据。

关键词: 小建中合剂, 活性炭, 高效液相色谱, 芍药苷, 干物质

Abstract:

To improve the clarity and stability of Xiaojianzhong mixture, the activated charcoal impurity removal process was selected to purify Xiaojianzhong mixture. The orthogonal test evaluation method was used; the evaluation factors were the amount of activated charcoal, boiling time, and the temperature of the solution during charcoal removal. Furthermore, the transfer rates of paeoniflorin and dry matter were used as evaluation indicators. Variance and visual analyses as well as accelerated stability tests were conducted to optimize the activated charcoal purification process for Xiaojianzhong mixture.In order to carry out these above experiments, three batches of Xiaojianzhong mixture preparations were produced for long-term stability testing. Results showed that the optimal parameters for the activated charcoal boiling purification process of Xiaojianzhong mixture preparations were 0.4% activated charcoal usage, 30 min of activated charcoal boiling time, and a liquid temperature of 100 ℃ during filtration. The average transfer rates of paeoniflorin and dry matter in expanded production under these process conditions were 75.24% and 89.08%, respectively. The optimal activated charcoal boiling purification process obtained from this test can ensure the clarity and stability of Xiaojianzhong mixture preparations while maximizing the retention of paeoniflorin and dry matter, thereby ensuring stable and uniform drug efficacy. This study provides a scientific and reasonable basis forclarifying and optimizing the parameters of the activated charcoal boiling purification process for Xiaojianzhong mixture.

Key words: Xiaojianzhong mixture, activated charcoal, HPLC, paeoniflorin, dry matter

中图分类号: 

  • R283.6

开放获取 本文遵循知识共享-署名-非商业性4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时表明是否对原文作了修改,不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0